Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-05-27
2008-05-27
Shiao, Rei-tsang (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
10829870
ABSTRACT:
Provided is a process for preparing valsartan and precursors thereof.
REFERENCES:
patent: 5260325 (1993-11-01), Markwalder et al.
patent: 5399578 (1995-03-01), Buhlmayer et al.
patent: 5965592 (1999-10-01), Buhlmayer et al.
patent: 6271375 (2001-08-01), Villa et al.
patent: 6294197 (2001-09-01), Wagner et al.
patent: 6395728 (2002-05-01), Webb et al.
patent: 6465502 (2002-10-01), Bullock et al.
patent: 6485745 (2002-11-01), Wagner et al.
patent: 2002/0132839 (2002-09-01), Ganter et al.
patent: 2003/0035832 (2003-02-01), Katakuse et al.
patent: 2003/0152620 (2003-08-01), Ganter et al.
patent: 2003/0207930 (2003-11-01), Marti et al.
patent: 2004/0072886 (2004-04-01), Reguri et al.
patent: 2004/0242661 (2004-12-01), Rukhman et al.
patent: 2005/0059827 (2005-03-01), Rukhman et al.
patent: 0 570 091 (1993-11-01), None
patent: 0 443 983 (1996-02-01), None
patent: WO 97/30036 (1997-08-01), None
patent: WO 99/01459 (1999-01-01), None
patent: WO 99/67231 (1999-12-01), None
patent: WO 01/82858 (2001-11-01), None
patent: WO 01/82858 (2001-11-01), None
patent: WO 02/06253 (2002-01-01), None
patent: WO 03/070246 (2003-08-01), None
patent: WO 03/089417 (2003-10-01), None
patent: WO 2004/026847 (2004-04-01), None
patent: WO 2004/083192 (2004-09-01), None
patent: WO 2004/087681 (2004-10-01), None
patent: WO 2004/094392 (2004-11-01), None
patent: WO 2005/089720 (2005-09-01), None
patent: WO 2005/102987 (2005-11-01), None
Peter Buhlmayer, et al.,Bioorgan.&Med. Chem. Lett., 4(1), 29-34 (1994).
Th.Moenius, et al.,J.Labelled Cpd. Radiopharm., 43(13) 1245-1252 (2000).
Qingzhong Jia, et al.,Zhongguo Yiyao Gongye Zazhi, 32(9) 385-387 (2001).
Borka L., et al., “Crystal Polymorphism of Pharmaceuticals”,Acta Pharm. Jugosl., 40, (1990) 71-94.
Merck Index (12thEdition, p. 1691, Valsartan n. 10051).
Zhong Guo, et al. Chinese Journal of Pharmaceuticals, 2002, pp. 385-387, vol. 32, part 9.
Harel Zvi
Rukhman Igor
Kenyon & Kenyon LLP
Shiao Rei-tsang
Teva Pharmaceutical Industries Ltd
LandOfFree
Process for the preparation of valsartan does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the preparation of valsartan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the preparation of valsartan will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3931829